Evaluation considerations for secondary uses of clinical data: principles for an evidence-based approach to policy and implementation of secondary analysis: A position paper from the IMIA Technology Assessment & Quality Development in Health Informatics Working Group
Research output: Contribution to journal › Article
Method - Working Group review of selected literature and policy approaches.
Results - We present important considerations in the evaluation of secondary uses of clinical data from the angles of governance and trust, theory, semantics, and policy. We make the case for a multi-level and multi-factorial approach to the evaluation of secondary uses of clinical data and describe a methodological framework for best practice. We emphasise the importance of evaluating the governance of secondary uses of health data in maintaining the trust, which is essential for such uses. We also offer examples of the re-use of routine health data to demonstrate how it can support evaluation of clinical performance and optimize health IT system design.
Conclusions - Great expectations are resting upon “Big Data” and innovative analytics. However, to build and maintain public trust, improve data reliability, and assure the validity of analytic inferences, there must be independent and transparent evaluation. A mature and evidence-based approach needs not merely data science, but must be guided by the broader concerns of applied health informatics.
|Number of pages||9|
|Journal||IMIA Yearbook of Medical Informatics|
|State||Published - 8 May 2017|
- Evaluation considerations for secondary uses of clinical data
Rights statement: This article is not an exact copy of the original published article in (journal title). The definitive publisher-authenticated version of (insert complete citation information here) is available online at: https://imia.schattauer.de/contents/archive/issue/special/manuscript/27504.html
Accepted author manuscript (Post-print), 402 KB, PDF-document